Found: 10
Select item for more details and to access through your institution.
A phase II randomized study of cetuximab and bevacizumab alone or in combination with gemcitabine as first-line therapy for metastatic pancreatic adenocarcinoma.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 4, p. 1597, doi. 10.1007/s10637-011-9691-8
- By:
- Publication type:
- Article
The attributable estimand: A new approach to account for intercurrent events.
- Published in:
- Pharmaceutical Statistics, 2020, v. 19, n. 5, p. 626, doi. 10.1002/pst.2019
- By:
- Publication type:
- Article
Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Exacerbation Outcomes in Patients with COPD without a Recent Exacerbation History: A Subgroup Analysis of KRONOS.
- Published in:
- International Journal of COPD, 2021, v. 16, p. 179, doi. 10.2147/COPD.S286087
- By:
- Publication type:
- Article
Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD.
- Published in:
- International Journal of COPD, 2019, v. 14, p. 2993, doi. 10.2147/COPD.S220861
- By:
- Publication type:
- Article
Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study.
- Published in:
- International Journal of COPD, 2019, v. 14, p. 2979, doi. 10.2147/COPD.S220850
- By:
- Publication type:
- Article
Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β<sub>2</sub>-Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Chinese Patients with COPD: A Subgroup Analysis of KRONOS.
- Published in:
- 2020
- By:
- Publication type:
- journal article
An Open-Label Phase II Study Evaluating the Safety and Efficacy of Ramucirumab Combined With mFOLFOX-6 as First-Line Therapy for Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2014, v. 19, n. 4, p. 350, doi. 10.1634/theoncologist.2014-0028
- By:
- Publication type:
- Article
Behavioral changes in patients with Prader-Willi syndrome receiving diazoxide choline extended-release tablets compared to the PATH for PWS natural history study.
- Published in:
- Journal of Neurodevelopmental Disorders, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s11689-024-09536-x
- By:
- Publication type:
- Article
Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study.
- Published in:
- 2021
- By:
- Publication type:
- journal article